Rafferty Asset Management’s Harmony Biosciences HRMY Stock Holding History

Rafferty Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+5,598	New	+$177K	﹤0.01%	1104
2026 Q1	–	Sell	-5,954	Closed	-$223K	–	1102
2025 Q4	$223K	Buy	+5,954	New	+$196K	﹤0.01%	1073
2025 Q2	–	Sell	-7,545	Closed	-$250K	–	1090
2025 Q1	$250K	Sell	7,545 -560	-7%	-$20.1K	﹤0.01%	999
2024 Q4	$279K	Buy	+8,105	New	+$278K	﹤0.01%	1039
2024 Q1	–	Sell	-7,374	Closed	-$238K	–	1087
2023 Q4	$238K	Buy	+7,374	New	+$206K	﹤0.01%	1046
2022 Q4	–	Sell	-5,223	Closed	-$231K	–	1133
2022 Q3	$231K	Buy	5,223 +26	+0.5%	+$1.27K	﹤0.01%	1066
2022 Q2	$253K	Buy	+5,197	New	+$234K	﹤0.01%	978
2022 Q1	–	Sell	-6,585	Closed	-$281K	–	1266
2021 Q4	$281K	Buy	+6,585	New	+$262K	﹤0.01%	1160

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rafferty Asset Management's HRMY Position: Q2 2026 in Review

Rafferty Asset Management opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 5,598 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1104 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in HRMY as recently as Q4 2025.

Rafferty Asset Management first reported a position in HRMY in Q4 2021 and has held it in 8 quarters since. The position peaked at $281K in Q4 2021. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Rafferty Asset Management held 5,598 shares of Harmony Biosciences worth $204K as of Q2 2026.
Harmony Biosciences was a new Rafferty Asset Management position in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1104 holding.
Rafferty Asset Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 8 quarters since.
Rafferty Asset Management's Harmony Biosciences position peaked at $281K in Q4 2021.
328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.